Cited by 170Microtubule and mitosis dynamicsGenetic and Kidney Cyst DiseasesCancer Treatment and Pharmacology

Tubulin Posttranslational Modifications and Emerging Links to Human Disease

Open access
Magiera, Maria M., Singh, Puja, Gadadhar, Sudarshan, Janke, Carsten·2018·Cell

Abstract

Tubulin posttranslational modifications are currently emerging as important regulators of the microtubule cytoskeleton and thus have a strong potential to be implicated in a number of disorders. Here, we review the latest advances in understanding the physiological roles of tubulin modifications and their links to a variety of pathologies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2018.05.018

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Induction of microtubule detyrosination by overexpressing VASH2-SVBP or MATCAP either did not impact the localization of GEF-H1 to microtubules or showed a slight increase in binding.

    “Induction of microtubule detyrosination (removal of the C-terminal tyrosine of α-tubulin), another modification associated with microtubule stability 31 , by overexpressing the detyrosinating enzymes VASH2-SVBP or MATCAP 56-58 , either did not impact the localization of GEF-H1 to microtubules or showed a slight increase in binding (Extended Data Fig. 4b-e).”

    From Taxane-induced conformational changes in the microtubule lattice activate GEF-H1-dependent RhoA signalling (2026) · cites this paper as [31]

    The indexed passage on detyrosination (section labeled Abstract; page unavailable) says that vasohibins catalyze tubulin detyrosination and cites work identifying vasohibins/SVBP as tubulin carboxypeptidases. It does not report VASH2-SVBP or MATCAP overexpression experiments, or whether detyrosination changes GEF-H1 localization or binding to microtubules; those results are attributed to the citing paper’s Extended Data Fig. 4b–e. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Microtubule stabilization can potentially affect microtubule-associated components of signalling cascades by altering their turnover and tubulin post-translational modifications.

    “However, microtubule stabilization can potentially affect microtubule-associated components of signalling cascades by altering their turnover and tubulin post-translational modifications 31 .”

    From Taxane-induced conformational changes in the microtubule lattice activate GEF-H1-dependent RhoA signalling (2026) · cites this paper as [31]

    The passage beginning “In living cells” (indexed as Abstract; no page supplied) says tubulin post-translational modifications can affect microtubule stability and interactions with microtubule-associated proteins. It does not say that stabilizing microtubules alters their turnover or modifications, or that this affects components of signalling cascades. (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Magiera, M. M., Singh, P., Gadadhar, S., & Janke, C.
Affiliations
Université Paris-Sud (FR)
Corresponding author
  • Magiera, Maria M.
  • Janke, Carsten
Venue
Cell
Publisher
Elsevier BV
Published
2018-05
Volume
173
Issue
6
Pages
1323-1327
ISSN
0092-8674 (ISSN-L)
OpenAlex
W2807269502
Cited by
169
References
51
Citations by year
2026: 11 · 2025: 14 · 2024: 17 · 2023: 21 · 2022: 18 · 2021: 17 · 2020: 36 · 2019: 28 · 2018: 7
FWCI
2.50
Type
journal article
Language
en
Open access
Locations
  • Cell (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
Funders
  • the French National Research Agency
  • ANR (ANR-10-LBX-0038, ANR-10-IDEX-0001-02 PSL, ANR-12-BSV2-0007)
  • Institut National du Cancer
  • INCA (2013-1-PL BIO-02-ICR-1, 2014-PL BIO-11-ICR-1)
  • EMBO (ASTF 148-2015)
  • Fondation Vaincre Alzheimer (FR-16055p.)
  • Ligue contre le Cancer
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
  • Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
Keywords
tubulin post-translational modifications, microtubule cytoskeleton, tubulin acetylation, microtubule dynamics, human disease, neurodegenerative diseases, cancer
MeSH terms
Animals, Blood Platelets, Cilia, Cytoskeleton, Flagella, Heart Diseases, Humans, Microtubules, Mutation, Phenotype, Protein Processing, Post-Translational, Risk Factors, Tubulin, Neurodegenerative Diseases, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review